Seer, Inc.
NASDAQ:SEERBiotechnology
+$0.01 today
- Market cap
- $80.37M
- Beta
- 1.59
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$1.26
Volume 0.23M
Average 0.32M
SEER Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Seer, Inc.NASDAQ: SEER
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $8.81M fell 22.4% year over year, behind the -11.2% change in trailing-twelve-month research & development. Sequentially, it fell 9.6% from the prior quarter. Over 3 fiscal years it compounded at -6.2% a year.
Context
- Research & development amounted to 234.3% of revenue in FY2025, down 128.4 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -22.4% toward the trailing-twelve-month pace of -11.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 37.77M USD
- Year-over-year change
- -25.3%
- 4-year CAGR
- +6.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 37.77M | -25.3% |
| FY2024 | 2024-12-31 | 50.59M | +6.6% |
| FY2023 | 2023-12-31 | 47.44M | +3.6% |
| FY2022 | 2022-12-31 | 45.8M | +57.3% |
| FY2021 | 2021-12-31 | 29.12M | — |
Research & Development vs competitors
How SEER compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -11.2% is the 14th highest of 19, against a peer median of -3.1%.
- Research & development amounts to 274.8% of revenue for SEER, versus a peer median of 357.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.27B USD | +18127.2% | -7.8% | 212494.0% | |
| LTM Jun 2026 | $375.6M USD | +29.1% | +24.5% | 357.8% | |
| LTM Aug 2026 | $331.95M USD | +10.2% | +18.6% | 47.3% | |
| LTM Jun 2026 | $301.59M USD | +72.6% | +71.3% | — | |
| LTM Mar 2026 | $188.07M USD | +22.3% | +26.8% | — | |
| LTM Mar 2026 | $153.38M USD | +23.0% | +18.5% | 357.1% | |
| LTM Mar 2026 | $151.83M USD | -11.7% | -0.1% | 489780.6% | |
| LTM Mar 2026 | $146.28M USD | -4.6% | -13.1% | — | |
| LTM Sep 2026 | €132.22M EUR | +7.0% | +29.5% | — | |
| LTM Mar 2026 | $116.62M USD | -0.1% | +21.2% | — | |
| LTM Mar 2026 | $101.77M USD | -11.6% | -4.0% | 291.9% | |
| LTM Mar 2026 | $88.91M USD | -7.1% | -0.2% | — | |
| LTM Mar 2026 | $82.1M USD | -9.4% | -6.8% | 290.9% | |
| LTM Mar 2026 | $58.35M USD | -32.7% | +9.5% | — | |
| LTM Mar 2026 | $54.53M USD | -11.0% | -9.3% | 2944.3% | |
| LTM Mar 2026 | CHF 46.97M CHF | -1.7% | -7.5% | — | |
| LTM Mar 2026 | $41.33M USD | -11.2% | -6.2% | 274.8% | |
| LTM Mar 2026 | $36.3M USD | -40.4% | -24.8% | 3629.9% | |
| LTM Mar 2026 | $23.82M USD | -28.9% | -5.7% | — | |
| Peer median (excluding SEER) | — | -3.1% | -0.1% | 357.8% | |
Competitors are the stored peer set for SEER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.39M | 14.69M | 15.18M | 13.95M | 16.12M |
| Cost of Revenue | 6.77M | 14.3M | 13.73M | 7.12M | 14.22M |
| Gross Profit | (374K) | 384K | 1.45M | 6.83M | 1.9M |
| Gross Margin | -5.8% | 2.6% | 9.5% | 49.0% | 11.8% |
| Research & Development | 29.12M | 45.8M | 47.44M | 50.59M | 37.77M |
| Selling, General & Admin | 42.2M | 52.63M | 58.95M | 56.57M | 42.58M |
| Operating Expenses | 71.32M | 98.43M | 106.39M | 106.93M | 80.35M |
| Depreciation & Amortization | 3.56M | 5.9M | 5.58M | 6.18M | 6.1M |
| EBITDA | (67.61M) | (87.07M) | (80.7M) | (80.33M) | (67.3M) |
| EBITDA Margin | -1057.3% | -592.9% | -531.5% | -575.9% | -417.5% |
| Operating Income | (71.7M) | (98.04M) | (104.94M) | (100.1M) | (78.45M) |
| Operating Margin | -1121.3% | -667.6% | -691.2% | -717.7% | -486.7% |
| Interest Income | 326K | 4.6M | 17.76M | 16.67M | 11.52M |
| Interest Expense | 22K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 527K | 5.08M | 18.67M | 13.6M | 5.05M |
| Income Before Tax | (71.17M) | (92.97M) | (86.28M) | (86.5M) | (73.4M) |
| Pre-Tax Margin | -1113.1% | -633.1% | -568.3% | -620.2% | -455.4% |
| Income Tax Expense | 0 | 0 | 0 | 98K | 201K |
| Net Income | (71.17M) | (92.97M) | (86.28M) | (86.6M) | (73.6M) |
| Net Margin | -1113.1% | -633.1% | -568.3% | -620.9% | -456.6% |
| EPS (Basic) | (1.13) | (1.42) | (1.35) | (1.39) | (1.28) |
| EPS (Diluted) | (1.13) | (1.42) | (1.35) | (1.39) | (1.28) |
| Weighted Avg Shares | 60.86M | 62.43M | 63.85M | 62.35M | 57.45M |
| Weighted Avg Shares (Diluted) | 60.86M | 62.43M | 63.85M | 62.35M | 57.45M |
Seer, Inc.
NASDAQ:SEER
Intrinsic Alpha fair value
Locked
Current Price
$1.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.